In a recent post, former Metamaterials CEO George Palikaras sheds light on the troubling dynamics of the Over-The-Counter (OTC) market, particularly focusing on the loopholes that allow for manipulation.

He draws attention to the situation surrounding the ticker symbol $MMTLP, which has become a focal point for discussions about market integrity and regulatory oversight.

Key Insights into OTC Market Regulation

Palikaras begins by exploring the historical context of SEC Rule 15c2-11, established in 1971.

This rule aims to regulate OTC securities by requiring broker-dealers to review issuer information before initiating quotes.

However, he highlights significant gaps in compliance mechanisms, particularly regarding unsolicited trades—transactions that occur without the issuer’s involvement or solicitation.

These gaps have raised serious concerns about the potential for manipulation, especially in light of the events surrounding $MMTLP.

Timeline of FINRA Rule 6432 Amendments

To illustrate the ongoing issues, Palikaras details a timeline of amendments to FINRA Rule 6432, which governs the quoting of non-exchange-listed securities.

He notes several key changes intended to strengthen oversight, such as:

• 2004: Initial compliance requirements were introduced, mandating broker-dealers to submit Form 211 to justify quotations. However, these rules lacked effective mechanisms to detect fraudulent submissions.
• 2008-2010: Subsequent amendments aimed at enhancing disclosure standards and cracking down on shell companies still failed to address persistent issues with unsolicited quotes, allowing market makers to exploit loopholes.
• 2021: Major overhauls were implemented to eliminate piggyback exemptions for shell companies, yet the efficacy of these changes was called into question as manipulative practices continued to surface in the $MMTLP case.

Exploitation Avenues Identified

Palikaras identifies five potential avenues through which broker-dealers exploit these regulatory gaps, showcasing the systemic vulnerabilities in the OTC market:

1. Misleading Form 211 Filings: Market makers submitted inaccurate or outdated information to justify listings. This practice creates an illusion of normal trading activity while obscuring the true financial status of the issuer.
2. Unsolicited Trade Exemptions: Brokers could disguise solicited trades as unsolicited, circumventing necessary documentation and regulatory scrutiny. This tactic undermines the integrity of the trading process.
3. Shell Company Recycling: The practice of using old CUSIPs to trade stocks that have ceased to exist functionally allows for continued trading activity without accountability. This recycling blurs the lines of legitimacy for new issuers.
4. Undisclosed Payments for Quotations: There are concerns about possible undisclosed financial incentives for quoting certain securities. Such arrangements could create conflicts of interest and lead to biased trading practices.
5. Algorithmic Surveillance Evasion: High-frequency trading algorithms can manipulate prices by executing numerous small trades to avoid detection. This sophisticated tactic raises alarms about the effectiveness of existing surveillance systems.

Related: Next Bridge will now seek market manipulation justice through Christian Attar

The Impact of Market Manipulation

Palikaras argues that the manipulation taking place within the OTC market not only affects individual stocks like $MMTLP but also has broader implications for larger exchanges such as Nasdaq.

The distorted trading activities create confusion among retail investors, leading to misguided trading decisions and increased short pressure on related stocks.

This kind of manipulation erodes trust in the market, leaving investors feeling vulnerable.

A Call for Regulatory Action

In his conclusion, Palikaras calls for deeper scrutiny of the OTC market and the enforcement of regulations designed to protect retail investors.

He suggests that the recent U3 halt on $MMTLP, categorized as an “extraordinary event,” may have been a defensive maneuver by regulators to shield the system from public exposure of its vulnerabilities.

By emphasizing the need for transparency and accountability in OTC trading practices, he urges investors to remain vigilant and aware of potential manipulation tactics.

His post serves as a critical reminder of the ongoing challenges within the OTC market and the pressing need for regulatory reform to ensure a fair and equitable trading environment for all participants.

Read Daily Market News for the latest in Finance, Business, Crypto, and more for retail investors.

Follow Frank Nez on X for more community insights.

Also Read: SEC Commissioner laments agency’s decision to fight against CAT system

---